Tag: Schizophrenia
AVATAR Therapy Promising for Auditory Hallucinations
Reduction in PSYRATS-AH total score significantly greater with AVATAR tx versus supportive counseling
Inflammatory Biomarkers May Impact Risk of Schizophrenia
Protective effect noted for C-reactive protein; risk-increasing effect for soluble interleukin-6 receptor
Specific Efforts May Aid Quality of Life for Schizophrenia Caregivers
Supportive interventions would cut affiliate stigma, enhance family-centered care
Targeted rTMS Effective for Auditory Verbal Hallucinations
Higher percentage of responders among patients in active transcranial magnetic stimulation group
Relapse Down With Clozapine, Injectables in Schizophrenia
Risk of rehospitalization substantially lower with long-acting injectables versus oral equivalents
Late Teen Emotional Stability Inversely Tied to Mental Illness
With unique U-shaped association seen for bipolar disorder and social maturity
Patients With Schizophrenia More Susceptible to Infections
Schizophrenia patients 63 percent more likely to suffer serious infection than the general population
Blood Test Promising for ID of Early Depression, Schizophrenia
NMDA receptor signaling increased in patients with depression, reduced in those with schizophrenia
Gestational Weight Gain Linked to Psychosis Risk in Children
Insufficient weight gain linked to increased risk for schizophrenia in offspring later in life
Exenatide Does Not Promote Weight Loss in Schizophrenia
No significant difference in weight loss for obese patients treated with exenatide, placebo
